RxDoctor Payments Data

Nhu Quynh Nguyen

Family · Aurora, CONPI 1558916866

Payments from drug & device makers

$666in general payments, 2019–2025

Across 32 payments — averaging $20.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$147
  • Amgen$120
  • Novartis$102
  • Mallinckrodt Hospital Products Inc.$84
  • Aurinia Pharma U.S., Inc.$49
  • Bayer$35
  • plus $129 from 6 others

What the payments were for

  • Food & beverage$666100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$666 in reported general payments places this provider in the 70th percentile of 2,182 family providers in Colorado.

See all family providers in Colorado

Medicare billing

Part B allowed, 2024
$24,637
Medicare patients
113
Services billed
298

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XphozahTenapanor Hcl21$57,096
LokelmaSodium Zirconium Cyclosilicate50$32,859
VelphoroSucroferric Oxyhydroxide15$31,860
FarxigaDapagliflozin Propanediol40$24,235
AuryxiaFerric Citrate11$22,532
Sevelamer Carbonate101$18,635
JardianceEmpagliflozin40$17,096
EliquisApixaban18$15,340
VeltassaPatiromer Calcium Sorbitex19$14,077
ProsolParenteral Amino Acid 20% No.147$9,930
ClinolipidFat Emulsion/Olive/Soy/Phospho23$4,465
Calcium Acetate29$3,709
PlenamineParenteral Amino Acid 15% No.644$2,667
Midodrine Hcl53$2,301
Labetalol Hcl15$884

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaLokelma, Farxiga$147$57,09390 claims
Akebia Therapeutics IncAuryxia$28$22,53211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,182 family providers in Colorado.

Other family in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →